National Surveillance Meticillin resistant Staphylococcus aureus in Belgian Hospitals

Until 2011 participation was semestrial, since 2012 data delivery is on yearly basis (but the database is still not adapted by the IT-team. Between 1994 and 2006 participation to the surveillance was not compulsory

Since 2006 each hospital is obliged to transmit MRSA data (at least 1 semester or for the whole year).

Eenerzijds laat het de opvolging van de evolutie van AMR toe, anderzijds wordt ook onrechtstreeks "quality of care" gemeten, m.n. in welke mate slaagt het ZH erin om overdracht van MRSA tegen te gaan (nosocomiale MRSA)

Data and Resources

National Surveillance Meticillin resistant Staphylococcus aureus in Belgian Hospitalsjson
Until 2011 participation was semestrial, since 2012 data delivery is on...
Download
datadictionary_MRSA_2013csv
Preview Download
Download All

Field	Value
Modified	2019-05-23
Release Date	2018-05-08
Identifier	27366752-2584-4fc5-805f-07fd42c918cd
License	Creative Commons Attribution
Public Access Level	Public

Protocol

Protocol
Full title of the project	National Surveillance Meticillin resistant Staphylococcus aureus in Belgian Hospitals
Title of the project for lay people, in easily understood, i.e. non-technical, language	National Surveillance Meticillin resistant Staphylococcus aureus in Belgian Hospitals
Name or abbreviated title of the project where available	NSIH AMR MRSA

Commissioner(s)

Organisation (1) that commissioned this project
Name of organisation (1)	Federal Public Service Health, Food Chain Safety and Environment - cell quality and patient safety
Website(s) of organisation (1)	Website

Organisation (2) that commissioned this project
Name of organisation (2)	Christiaan Decoster

Source(s) of Monetary or Material Support

Organisation (1) providing support
Name of organisation (1)	Federal Public Service Health, Food Chain Safety and Environment - cell quality and patient safety
Website(s) of organisation (1)	Website

Organisation (2) providing support
Name of organisation (2)	National Institute for Health and Disability Insurance
Website(s) of organisation (2)	Website

Additional information	Deelname aan deze surveillance ligt vast in het KB ivm financiering van ziekenhuizen voor deelname aan de surveillance van zorggerelateerde infecties in ziekenhuizen. De financiering wordt geregeld via het KB van 10 november 2006 (Staatsblad: 24/11/2006) en via het KB van 19 juni 2007. National Institute for Health and Disability Insurance: funding for the data collection by healthdata.be.

Governance

Governance
Is there a Steering / Accompanying committee?	Yes
Name of Steering/Accompanying Committee (1)	National reference center, Erasmusziekenhuis ULB (Université Libre de Bruxelles)
Composition of Steering/Accompanying Committee (1)	Dr. Olivier Denis
Name of Steering/Accompanying Committee (2)	Belgian Infection control Society
Composition of Steering/Accompanying Committee (2)	zie www/belgianinfectioncontrolsociety.be

General information

Objective of the project
Main objective of the project	De doeleinden van deze surveillance zijn: De evolutie van het resistentiecijfer en het nosocomiaal incidentiecijfer van MRSA in acute ziekenhuizen op te volgen in de tijd en relevante gegevens in verband met deze resistente kiem te verzamelen voor België. De deelnemende ziekenhuizen in staat te stellen om lokale MRSA resultaten op te volgen in de tijd en deze te vergelijken met de nationale resultaten.

Scope
Scope	Epidemiology Quality of care research

Legal basis

Type of legal basis
Type of legal basis	National Law Royal Decree

Legal documents
Full reference of legal document (1)	10 november 2006. - Koninklijk besluit tot wijziging van het koninklijk besluit van 25 april 2002 betreffende de vaststelling en de vereffening van het budget van financiële middelen van de ziekenhuizen (Publicatie: 24 november 2006)
URL to legal document (1)	http://www.ejustice.just.fgov.be/mopdf/2006/11/24_2.pdf#Page86
Full reference of legal document (2)	19 juni 2007. - Koninklijk besluit tot wijziging van het koninklijk besluit van 25 april 2002 betreffende de vaststelling en de vereffening van het budget van financiële middelen van de ziekenhuizen. (Publicatie: 28 juni 2007)
URL to legal document (2)	http://www.ejustice.just.fgov.be/cgi_loi/change_lg.pl?language=nl&la=N&table_name=wet&cn=2007061933

Design of the project

Principal inclusion and exclusion criteria
Principal inclusion criteria	De surveillance bestaat uit een drieluik: (1) MRSA (verplichte deelname 6md of 1 jaar) (2) Gram-negatieve bacteriën (verplichte deelname, 6 md of 1 jaar) (3) VRE (optionele deelname, 1 volledig kalenderjaar) Alle gehospitaliseerde patiënten waarvoor een pathogeen (S. aureus, E. coli, K. pneumoniae, E. cloacae, A. baumannii, P. aeruginosa, E. faecium, E. faecalis) werd geïdentificeerd inclusief antibiogram en/of enzymatisch resistentiemechanisme.

Data transfer frequency
Data transfer frequency	Yearly
Other frequency: specification	Until 2011, data were provided by semester. Since 2011 hospitals provide data for 1 semester or for a whole year. They deliver data once a year (before 30/04/yyyy).

Method of data transfer
Data transfer method(s)	E-mail (secured) E-mail (unsecured) eHealthbox of eHealth Platform Post Secured file transfer protocol (SFTP) Web application (eg. online registration form, upload)

Sites involved in the project

Type of site(s)
Care Provider	Centers for rehabilitative stay General hospitals

Health professionals involved (encoding) in the project

Health professionals involved (encoding) in the project
Care Giver	Microbiologists Nurses Other Pharmacists Physicians
Specialty of physicians involved (encoding) in the project	Acute medicine Clinical biology

Informed consent

Informed consent
Are subjects informed?	No information available
How are subjects informed?	No information available
Do subjects have to give their consent?	No information available
How do subjects give their consent?	No information available
Is there a procedure to provide subjects the ability to consult their registered information?	No information available
Is there a procedure to provide subjects the ability to correct their registered information?	No information available
Additional information	Consent for use, consultation and correction of individual patient data are regulated/managed by the individual healtcare setting (hospital), mostly by patient signature at admission in the hospital.

Review

Ethics Committee
Authorization by an Ethics Committee?	No

Sectoral Committee National Registry (Privacy Commission)
Authorization by the sectorial committee Health / Social affairs of the Privacy Commission	No

Sectoral Committee Health / Social affairs (Privacy Commission)
Authorization by the sectorial committee Health / Social affairs of the Privacy Commission	Yes
Full name committee	Sectoraal Comité van de Sociale Zekerheid en van de Gezondheid
Date of decision	2016-12-20
Title decision	BERAADSLAGING NR. 16/111 VAN 20 DECEMBER 2016 BETREFFENDE DE MEDEDELING VAN GECODEERDE PERSOONSGEGEVENS DIE DE GEZONDHEID BETREFFEN VIA HET HEALTHDATA-PLATFORM IN HET KADER VAN DE OPVOLGING VAN ZORGINFECTIES EN ANTIMICROBIELE RESISTENTIE
Nr. Decision	SCSZG/16/245

Sectoral Committee Crossroads Bank of Enterprises (Privacy Commission)
Authorization by the sectorial committee Crossroads Bank of Enterprises of the Privacy Commission (Y/N)	No

Data quality

Data quality
First year for which data is available	1994
Procedures for checking and validating the source data	Validation levels are incorporated in the data collection process: Validation rules: validation rules are the set of predefined and functional definitions that are defined by the responsible researcher of organization. Every new registration entered in the application needs to comply to these validation rules before they can be transferred. Revision: a revision of the data is done by the responsible researcher after receiving the data to exclude any anomaly that was not detected by the validation rules.
Data compilation process	please consult quality system (analyseplan)
Punctuality for the most recent completed data collection: the data collection was completed	Less then 1 year (but more than 6 months) after the communicated deadline
Participation rate of the health institutions	Very high (80-100%)
Participation rate of the health professionals	No information available
Extent of unit non-response	Very low or none (0-4%)
Extent of the item non-response	There is nearly no item non-response
Necessity of editing the raw data	There is a lot of item non-response (15% to under 50%)
Extend to which the collected data are comparable across the Belgian regions	Not applicable
Comparable or reconcilable over time	There are no restrictions concerning comparability over time
Additional information	The way of data collection and transmission is the same in the different regions (SP005). Nevertheless, MRSA outcomes are different by region. This is not attributable to the data collection method but to the regional epidemiology of AMR. The surveillance contains a set of compulsory variables and also some optional data (non-response to these should not be considered as missing data).
Extent of problems with the misclassification of statistical units for their key variables	Not applicable
Can records belonging to same entity be matched?	Yes, no restriction in time

Data storage

Data storage
Total number of unique records	3597
The organisation in charge of storage of the collected data, is certified as being compliant with the international standards on information security management system (eg. ISO27001)?	No

Data access

Data access
Written Data sharing policy?	No

Request data

Primary tabs

License

Other Access